Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
Warner Greene, Director of the Gladstone Institute of Virology and Immunology, quoted in the San Francisco Business Times about the recent Ebola outbreak and the risk for infection here in the U.S.
The Director of the Gladstone Institute of Virology and Immunology, Warner Greene, comments on the recent Ebola outbreak in West Africa and the appropriate response to a possible patient in Sacramento.
Nobel Prize laureate Shinya Yamanaka, one of the world's most revered stem-cell researchers, takes part in "ice bucket challenge."
Conference aims to highlight differences in prevention and treatment around the world
Researchers developing stem cell therapy to bolster immune system.
Several concerns about a prescription drug used to prevent HIV infection in people at high risk are being put to rest by the results of new research.
There is more good news about HIV treatment pills used to prevent infection in people at high risk of getting the AIDS virus: Follow-up from a landmark study that proved the drug works now shows that it does not encourage risky sex and is effective even if people skip some doses.
Truvada, the once-a-day pill to help keep people from contracting H.I.V., is on the cover of this week’s New York magazine, discussing how the pill is changing sex by drastically reducing gay men’s fear of infection.
Direct reprogramming of cardiac muscle cells into pacemaker cells gives pig hearts back their rhythm.
A new study by U.S. scientists revealed a way to alleviate the learning and memory deficits caused by a gene linked to Alzheimer's disease. By transplanting new cells into the brain, they saw improved brain activity, restoring cognition to normal levels in elderly mice.